Still, there are no clearly known mechanisms by which HPS develops in these pathologies 13. Currently, it is calculated that 4% to 8% of the hepatopulmonary cases occur in patients with non-cirrhotic portal hypertension. The literature about the coexistence of HPS in patients with non-cirrhotic portal hypertension is limited to case reports and controlled studies with small sample sizes.
Actualmente se calcula que 4-8% de los casos de síndrome hepatopulmonar se presentan en pacientes con hipertensión portal no cirrótica; la literatura acerca de la coexistencia de SHP en pacientes con hipertensión portal no cirrótica se limita a reportes de casos y estudios controlados de pequeños tamaños muestrales.